The effect of adenosine in insulin secretion and adenylate cyclase activity of rat islets of Langerhans was investigated. Adenosine inhibited insulin secretion stimulated by glucose, glucagon, prostaglandin E2, tolbutamine and theophylline. Adenosine decreased basal adenylate cyclase activity of the islets as well as that stimulated by glucagon, prostaglandin E2 and GTP, although fluoride-stimulated activity was not affected. Neither insulin secretion nor adenylate cyclase activity of the islets was affected by adenine, AMP or ADP. The inhibitory effect of adenosine on adenylate cyclase activity was not altered by either phenoxybenzamine (ac-adrenergic blocker) or propranolol (fi-adrenergic blocker), suggesting that the effect is not mediated through the adrenergic receptors of the islet cells. These results suggest that the intracellular concentration of adenosine in the fl-cell may play a role in regulating insulin secretion and that this effect may be mediated via alterations in the activity of adenylate cyclase in the fl-cell.
(Received 11 November 1976) The effect of adenosine in insulin secretion and adenylate cyclase activity of rat islets of Langerhans was investigated. Adenosine inhibited insulin secretion stimulated by glucose, glucagon, prostaglandin E2, tolbutamine and theophylline. Adenosine decreased basal adenylate cyclase activity of the islets as well as that stimulated by glucagon, prostaglandin E2 and GTP, although fluoride-stimulated activity was not affected. Neither insulin secretion nor adenylate cyclase activity of the islets was affected by adenine, AMP or ADP. The inhibitory effect of adenosine on adenylate cyclase activity was not altered by either phenoxybenzamine (ac-adrenergic blocker) or propranolol (fi-adrenergic blocker), suggesting that the effect is not mediated through the adrenergic receptors of the islet cells. These results suggest that the intracellular concentration of adenosine in the fl-cell may play a role in regulating insulin secretion and that this effect may be mediated via alterations in the activity of adenylate cyclase in the fl-cell.
Evidence has accumulated which suggests that adenosine may play an important role in regulating carbohydrate and lipid metabolism in a variety of tissues. Thus it mimics the action of insulin on glucose and lipid metabolism in adipocytes (Dole, 1962; Fain, 1973; Schwabe et al., 1974) and affects various aspects of metabolism in hepatocytes (Lund et al., 1975) and reticulocytes (Harbon & Chapeville, 1970) . Further studies in vivo (Chagoya De Sainchez et al., 1974) have shown that adenosine produces moderate hyperglycaemia in rats.
Since it was possible that effects of adenosine on blood glucose might be mediated via alterations in the rate of insulin secretion, we have investigated its effect on insulin secretion by isolated rat islets of Langerhans. We have used islets of Langerhans isolated from rat pancreas, since they provide a system in vitro that is highly sensitive to the effects of a variety of secretagogues on insulin release (Montague & Taylor, 1968) and because adenosine has been shown to penetrate the cells (Miller et al., 1972) . We have attempted to correlate the effect of adenosine on insulin secretion with its effect on islet adenylate cyclase, since adenosine has been shown to affect adenylate cyclase activity of different tissues (Fain et al., 1972; Blume & Foster, 1975) and it has been established that cyclic AMP plays an important role in regulating insulin secretion (Montague & Howell, 1975 Howell & Taylor (1968) and Montague & Taylor (1968) .
Insulin secretion from isolated rat islets. This was determined as described in detail by Green & Taylor (1972) . Islets were preincubated for 30min at 37°C in a bicarbonate-buffered medium (Gey & Gey, 1936) containing 2 mM-glucose. The incubation medium for insulin-secretion studies contained either 8 mM-glucose alone or 8 mM-glucose plus the agent under study, and thegasphasewasO2/CO2 (19: 1). The medium was supplemented with bovine serum albumin fraction V (1 mg/ml). Additions to the incubation medium were as indicated in the Results and Discussion section. The islets were incubated in 0.6 ml ofincubation buffer in groups of three at 37°C for 60min with gentle shaking. At the end of this period, a sample of the medium was removed and diluted for the determination of its insulin content.
Insulin assay. Insulin was assayed in duplicate, by using a double-antibody technique based on that of Hales & Randle (1963) with reagents basically used for the immunoassay of human insulin. These reagents react with equal sensitivity to rat insulin, and therefore can be used to determine rat insulin (Montague & Taylor, 1968) . Adenylate cyclase assay. Adenylate cyclase activity was determined by the method of Salomon et al. (1974) . Portions (50,ul) of islet homogenate whose protein content was in the range 25-75 ,g were mixed with 50,ul of a mixture containing 25mM-Tris/HCI, 1 mM-EDTA, 1 mg of albumin/ml, 5 mM-MgCI2, 1.OmM-3-isobutyl-1-methylxanthine and 0.1 mm-[_-32P]ATP (1 x 106c.p.m.). Phosphocreatine (20mM) and creatine kinase (1 mg/ml) were added as an ATPregenerating system. The mixture was incubated at 37°C for 20 min with or without the additions shown in the Results and Discussion section.
Reaction blanks from which homogenate was omitted were included in each experiment. The reaction was terminated at the end of the incubation period by immersion of the tubes in a boiling-water bath for 2min. Cyclic AMP (60,ug) Lowry et al. (1951) , with bovine serum albumin as standard.
Results and Discussion
Numerous studies have been performed to investigate the effects of adenine and guanine Glucose concentration (mM) Montague & Howell, 1975) , although little attention has been paid to the effects of nucleosides other than inosine (Capito & Hedeskov, 1976 Tolbutamide (1 mM) 6.3 ± 0.8 (7) 3.1 + 0.4* (9) Theophylline (1 mM) 5.6 + 0.2 (7) 3.6 + 0.4* (9) * Significant difference between absence and presence of adenosine (P<0.01). penetrate and be metabolized by islets of,Langerhans (Miller et al., 1972) , we have investigated its effects on insulin release from the fa-cell.
Adenosine (10piM) inhibited insulin release from islets of Langerhans stimulated by various concentrations of glucose (Table 1 and Fig. 1 ) and inhibited insulin release by glucagon, prostaglandin E2, theophylline and tolbutamide (Table 2 ). An inhibitory effect of adenosine in insulin secretion in vivo might account for the hyperglycaemia produced by the administration of adenosine to rats (Chagoya De Sainchez et al., 1974) . The ability of adenosine to inhibit the secretory response of the fl-cell to such a wide range of stimuli suggests that it may act at a site of fundamental importance to the release mechanism. Adenosine decreased the effectiveness of all stimulatory glucose concentrations on insulin secretion (Fig. 1) . A similar effect has been observed with imidazole and catecholamines, which decrease the effectiveness of different concentrations ofglucose on insulin secretion by lowering the cyclic AMP concentration in the fl-cell (Montague & Howell, 1975) . In addition, adenosine inhibited the effect of theophylline, glucagon and prostaglandin E2 on insulin release, and these agents appear to act by increasing cyclic AMP concentrations in the fl-cell.
These results suggest that the effect of adenosine on insulin release might be related to the cyclic AMP system of the fl-cell. Similar effects of adenosine in inhibiting cyclic AMP-mediated effects have been reported in adipocytes (Fain, 1973) , heart (Schwabe et al., 1974 ) and brain (Huang et al., 1973) .
Receptors for adenosine linked to adenylate cyclase have been reported in a variety of tissues. Thus adenylate cyclase activity of adipocytes (Fain et al., 1972) , lung (Weinryb & Michel, 1974) and liver (Moriwaki & Foa, 1970) was inhibited by adenosine, Vol. 164 whereas the activity of adenylate cyclase in other tissues such as platelets (Holmsen & Day, 1971 ) and brain (Huang et al., 1973) was stimulated. The results in Table 3 show that adenosine inhibits glucagon-and prostaglandin E2-stimulated adenylate cyclase activity of the islet cells, although fluoridestimulated adenylate cyclase was not affected (Table  4 ). The percentage inhibition by adenosine of glucagon-and prostaglandin-stimulated adenylate cyclase closely parallels the percentage inhibition of insulin release produced by adenosine in the presence ofthese Table 3 . Effect ofadenosine onglucagon-andprostaglandin E2-stimulated adenylate cyclase activity of rat islets of Langerhans Adenylate cyclase was determined as described in the text. Each value represents the mean±S.E.M. of six observations. The cyclic AMP formed is expressed as percentage of basal activity of freshly prepared homogenate. 79.0+ 6.6* 121.5 ± 6.6* 98.0+ 6.5 66.7 + 8.6* 116.3 ± 7.6* 65.9 ± 6.2* * Significant difference from the basal activity (P<0.05). Table 4 . Effect of adenosine on fluoride-, GTP-, glucagonand prostaglandin E2-stimulated adenylate cyclase activity ofrat islets ofLangerhans Adenylate cyclase activity in response to fluoride, GTP, glucagon and prostaglandin E2 was determined as described in the text, in the presence and absence of adenosine. Each value is the mean±S.E.M. for the number of observations shown in parentheses.
Adenylate cyclase activity (pmol of cyclic AMP/min per mg of protein) Additions -Adenosine +Adenosine (10pM) None (basal) Fluoride (10mM) GTP (0.1 mM) Glucagon(20g/ml)+ GTP (0.1 mM) Prostaglandin E2 (I 0pM)+GTP (0.1 mM) 40± 3 (15) 235± 18 (6) 55± 2 (6) 59+ 3 (6) 24±2* (15) 222+9 (6) 42±3* (6) 39±3* (6) 56± 1 (5) 40±1* (7) * Significant difference from control between absence and presence of adenosine (P<0.01).
agents. This suggests that the inhibitory effect of adenosine on insulin release may be mediated via an effect on islet-cell adenylate cyclase whichdecreases intracellular cyclic AMP concentration in the fl-cell.
This effect appears to be specific for adenosine, since adenine, AMP and ADP had no effect on either insulin release or adenylate cyclase activity (Table 1) .
These findings are consistent with the observations that adenosine, but not adenine, AMP or ADP, also affects the cyclic AMP content and adenylate cyclase activity of cerebral cortex (Sattin & Rall, 1970) , adipocytes (Fain et al., 1972; Schwabe et al., 1973) and bone cells (Peck et al., 1976) . Studies on the mode of action of adenosine in regulating adenylate cyclase activity have suggested that adenosine does not interact with a-and ,B-adrenergic receptors linked to adenylate cyclase in a variety of tissues (Clark et al., 1974; Zenser, 1975) . The results in this study suggest that adenosine does not exert its effect on islet-cell adenylate cyclase by interaction with adrenergic receptors in the fl-cell, since its effect was not modified in the presence of phenoxybenzamine, an oc-adrenergic blocker, or propranolol, a ,B-adrenergic blocker (Table 5) .
The suggestion that GTP might be involved in the activation of liver and islet-cell adenylate cyclase (Rodbell et al., 1971; Howell & Montague, 1973) prompted us to investigate the effect of adenosine on GTP-stimulated adenylate cyclase activity of the islets. The results in Table 4 show that adenosine inhibited the effect of GTP on adenylate cyclase activity in the presence and absence of glucagon and prostaglandin E2. Since adenosine inhibited basal, GTP-and hormone-stimulated adenylate cyclase but not fluoride-stimulated activity, the site of action of adenosine may be related to the. receptor or (1 OUM) 79.0 + 6.6* Phenoxybenzamine (0.1 mM) 71.7 + 4.9* Adenosine (10gM)+phenoxybenz-55.3 ± 4.5* amine (0.1 mM) Propranolol (0.1 mM) 90.3 + 8.6 Adenosine (10,M)+propranolol 71.5 ± 5. 1 * (0.1 mM) * Significant difference from the basal activity (P < 0.05).
coupling component of adenylate cyclase rather than to the catalytic component.
It has been suggested (Fain et al., 1972 ) that adenosine might play a physiologically important role as an intracellular feedback regulator of fat-cell adenylate cyclase which may be important in the physiological regulation of lipolysis. The results of the present study suggest that a similar mechanism may operate in the fl-cell, since it has been demonstrated that adenosine at a fairly low concentration inhibits insulin release via an effect on islet adenylate cyclase. Such a mechanism might be important in modulating the secretory response of the fl-cell to glucagon and prostaglandin E2, and to other agents such as secretin and pancreozymin which affect the release process by activating adenylate cyclase in the fl-cell (Montague & Howell, 1975) . Thus the intracellular concentration of adenosine in the fl-cell may play a role in regulating insulin secretion, an effect which may be mediated via alterations in the activity of adenylate cyclase in the fl-cell.
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